| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.29 | 2e-08 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-07 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.16 | 7e-07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |